Cytodyn Inc (CYDY)

[Saltz]

I’m here.

You need to network your way in to Paulson and get approved as an accredited investor. Net worth $1million and annual income I believe min 200k. Its a bunch of BS but their are hurdles to qualify to take lesser risk than buying on the open market. Lol. The big difference is your shares are restricted so that’s the reason for the barrier to entry. I own 100k shares purchased on the open market and my average is lower than my much larger Paulson position. At this point if I was starting a position the Paulson matching warrants at a fire sale price would seem to be the only way to go. I will tell you these small raises subscribe overnight as they are sold to previously approved credited investors.

On another note. The recent minuscule Paulson offering is a non event as they will continue to raise in small increments regardless of how bullish they are regarding the news around the corner. There have been events that management absolutely believed would move the SP that did not so they are cautious as to expectations that great data at the June ASM will finally turn the tide.

Sorry to throw a bit of a wet blanket on the current situation but that’s the way I see it. I’m still a believer that the science will have its day, however the warrant fueled Paulson raises have and will continue to keep a lid on the SP. Currently that lid is 50 cents. Until we break free from Paulson thats where we stay.

Finesand is on track as to the calculated market valuation of Pro-140 and the events that will bring the current SP into alignment. How much evidence it will take is the debate that constantly takes place here on this forum. As one wise investor stated long ago on this forum, you may want to manage your energy on a monthly basis rather than a daily basis with this type of investment or you will become fatigued.

IMHO we need a partner with the resources to commercialize Combo and expedite Mono Trial enrolled to push the envelope. Bottom line is Combo got bogged down and economically compromised Mono enrollment. Mono should have been completely enrolled last year. Time is money and time is kicking our ass at this juncture. BP knows our predicament and they are hoping we run out of gas. As Tony C has said biotech’s don’t go BK from diluting, so we will keep on advancing the clinical trials with the hope that a tipping point is inevitable.

GLTAL